Qiagen N.V. (QGEN) Stock Overview

NYSE · Healthcare · Diagnostics & Research

✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026

$43.47
Price
$8.98B
Market Cap
22.07
P/E Ratio
$1.97
EPS
$57.82
52-Week High
$32.53
52-Week Low
0.81%
Dividend Yield
USD
Currency

About Qiagen N.V.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping,…

Source: Yahoo Finance

Sector & Industry

Qiagen N.V. operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NYSE exchange.

Qiagen N.V. at a Glance

CompanyQiagen N.V.
TickerQGEN
ExchangeNYSE
CurrencyUSD
Price$43.47
Market cap$8.98B
P/E ratio (trailing)22.07
EPS (trailing)$1.97
52-week high$57.82
52-week low$32.53
Dividend yield0.81%
Ex-dividend date07 Jul 2026
Beta0.63
Return on equity (ROE)11.93%
Debt-to-equity49.25%
Average volume2.89M
Shares outstanding206.50M
SectorHealthcare
IndustryDiagnostics & Research
Employees5,500
CountryNetherlands

Investing Essentials

As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.

AMAZON Dividend Investing Guides

Top-rated books on building an income portfolio from dividend payers.

Check Price →
AMAZON The Little Book of Big Dividends

A practical framework for judging whether a dividend is safe and worth owning.

Check Price →
AMAZON Healthcare Investing Reads

Evaluating pharma pipelines, devices and healthcare economics.

Check Price →
Disclaimer: This page is for reference only. Not financial advice. Data is a snapshot and may be out of date. Always verify with a licensed broker.

Frequently Asked Questions

What is Qiagen N.V.'s current P/E ratio?
Qiagen N.V. (QGEN) has a trailing P/E ratio of 22.07 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
What is Qiagen N.V.'s market capitalisation?
Qiagen N.V.'s market cap is $8.98B based on our latest snapshot. See how it ranks by market cap →
What is QGEN's 52-week range?
Over the past 52 weeks, QGEN has traded between $32.53 and $57.82. What does the 52-week range mean? →
How volatile is Qiagen N.V. compared to the market?
Qiagen N.V. has a beta of 0.63, meaning it has historically moved less than the broader market. What does beta measure? →
Does Qiagen N.V. pay a dividend?
Qiagen N.V.'s trailing annual dividend yield is 0.81%. Compare with other high-yield stocks →
What exchange is QGEN listed on?
QGEN is listed on the NYSE. Browse all NYSE-listed stocks →
What sector is Qiagen N.V. in?
Qiagen N.V. is classified in the Healthcare sector. Compare with Healthcare peers →

Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.

Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.

Recommended Reading & Tools

AMAZON The Psychology of Money

Morgan Housel's short lessons on behaviour, luck and long-term wealth.

Check Price →
AMAZON One Up On Wall Street

Peter Lynch on how everyday investors can spot winners before the professionals do.

Check Price →
AMAZON The Intelligent Investor

Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.

Check Price →

Related Healthcare Stocks